Tumor-suppressive microRNAs in Lung cancer: diagnostic and therapeutic opportunities

Lorenzo F Sempere1, Xi Liu, Ethan Dmitrovsky

  • 1Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. Lorenzo.F.Sempere@Dartmouth.EDU

Insights

Researchers identified a signature of down-regulated microRNAs in lung cancer, crucial for understanding cancer biology and developing new therapies. Restoring specific microRNAs inhibited lung cancer cell proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer is a leading cause of cancer death, characterized by diverse molecular and clinical features.
  • microRNAs (miRNAs) are short, noncoding RNAs regulating gene expression and are implicated in various diseases.
  • Improved diagnostic and therapeutic strategies are essential for effective lung cancer management.

Purpose of the Study:

  • To identify microRNA expression profiles in lung cancer.
  • To investigate the role of specific microRNAs in lung cancer cell proliferation.
  • To explore the clinical implications of microRNA dysregulation in lung cancer.

Main Methods:

  • Genome-wide microRNA expression analysis in mouse transgenic lung cancer models.
  • Validation of microRNA signatures in clinical specimens from lung cancer patients.
  • In vitro experiments assessing the impact of restoring specific microRNA expression on cancer cell proliferation.

Main Results:

  • A distinct signature of down-regulated microRNAs was identified in lung cancer tissues compared to normal lung tissue.
  • This microRNA signature was validated in human lung cancer specimens.
  • Restoring expression of miR-34c, miR-145, or miR-142-5p significantly reduced lung cancer cell proliferation in vitro.

Conclusions:

  • Dysregulated microRNAs play a significant role in lung cancer development and progression.
  • The identified microRNA signature holds potential for diagnostic and therapeutic applications in lung cancer.
  • Targeted restoration of specific microRNAs may offer a novel strategy for lung cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...